Vascular dysfunction and heart failure: Epiphenomenon or etiologic agent?

被引:42
作者
Fang, ZY [1 ]
Marwick, TH [1 ]
机构
[1] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1067/mhj.2002.120780
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial function plays a key role in the local regulation of vascular tone. Alterations in endothelial function may result in impaired release of endothelium-derived relaxing factors or increased release of endothelium-derived contracting factors. Heart failure may impair endothelial function by means of reduced synthesis and release of nitric oxide (NO) or by increased degradation of NO and increased production of endothelin-1. Endothelial dysfunction may worsen heart function by means of peripheral effects, causing increased afterload and central effects such as myocardial ischemia and inducible nitric oxide synthase (iNOS)-induced detrimental effects. Evidence from clinical studies has suggested that there is a correlation between decreased endothelial function and increasing severity of congestive heart failure (CHF). Treatments that improve heart function may also improve endothelial dysfunction. The relationship between endothelial dysfunction and heart failure may be masked by the stage of endothelial dysfunction, the location of vessels being tested, and the state of endothelial-dependent vasodilatation response.
引用
收藏
页码:383 / 390
页数:8
相关论文
共 53 条
[1]   Complete coding sequence of inducible nitric oxide synthase from human heart and skeletal muscle of patients with chronic heart failure [J].
Adams, V ;
Krabbes, S ;
Jiang, H ;
Yu, JT ;
Rahmel, A ;
Gielen, S ;
Schuler, G ;
Hambrecht, R .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1998, 2 (04) :242-249
[2]   Serum from patients with severe heart failure downregulates eNOS and is proapoptotic -: Role of tumor necrosis factor-α [J].
Agnoletti, L ;
Curello, S ;
Bachetti, T ;
Malacarne, F ;
Gaia, G ;
Comini, L ;
Volterrani, M ;
Bonetti, P ;
Parrinello, G ;
Cadei, M ;
Grigolato, PG ;
Ferrari, R .
CIRCULATION, 1999, 100 (19) :1983-1991
[3]   LARGE ARTERY FUNCTION IN PATIENTS WITH CHRONIC HEART-FAILURE - STUDIES OF BRACHIAL-ARTERY DIAMETER AND HEMODYNAMICS [J].
ARNOLD, JMO ;
MARCHIORI, GE ;
IMRIE, JR ;
BURTON, GL ;
PFLUGFELDER, PW ;
KOSTUK, WJ .
CIRCULATION, 1991, 84 (06) :2418-2425
[4]   Endothelium-dependent relaxation is not uniformly impaired in chronic heart failure [J].
Baggia, S ;
Perkins, K ;
Greenberg, B .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (03) :389-396
[5]  
Bank A J, 1994, J Card Fail, V1, P35, DOI 10.1016/1071-9164(94)90006-X
[6]   Relation between impairment in nitric oxide pathway and clinical status in patients with congestive heart failure [J].
Carville, C ;
Adnot, S ;
Sediame, S ;
Benacerraf, S ;
Castaigne, A ;
Calvo, F ;
de Cremou, P ;
Dubois-Randé, JL .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (04) :562-570
[7]   PLASMA ENDOTHELIN CORRELATES WITH THE EXTENT OF PULMONARY-HYPERTENSION IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE [J].
CODY, RJ ;
HAAS, GJ ;
BINKLEY, PF ;
CAPERS, Q ;
KELLEY, R .
CIRCULATION, 1992, 85 (02) :504-509
[8]   ABC of heart failure - History and epidemiology [J].
Davis, RC ;
Hobbs, FDR ;
Lip, GYH .
BRITISH MEDICAL JOURNAL, 2000, 320 (7226) :39-42
[9]   Increased malondialdehyde in peripheral blood of patients with congestive heart failure [J].
DiazVelez, CR ;
GarciaCastineiras, S ;
MendozaRamos, E ;
HernandezLopez, E .
AMERICAN HEART JOURNAL, 1996, 131 (01) :146-152
[10]   Hypertension, heart failure, and endothelial function [J].
Drexler, H .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (10A) :20S-22S